Label: LEVOCETIRIZINE DIHYDROCHLORIDE tablet, film coated

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated April 15, 2021

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENT(S)

    Levocetirizine dihydrochloride USP 5 mg


  • PURPOSE

    Antihistamine

  • USE(S)

    temporarily relieves these symptoms due to hay fever or other respiratory allergies:
    • runny nose
    • sneezing
    • itchy, watery eyes
    • itching of the nose or throat


  • WARNINGS

  • DO NOT USE

    • if you have kidney disease
    • if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing cetirizine



  • ASK A DOCTOR BEFORE USE IF YOU HAVE

    • ever had trouble urinating or emptying your bladder
  • WHEN USING THIS PRODUCT

    •  drowsiness may occur
    •  avoid alcoholic drinks
    • alcohol, sedatives, and tranquilizers may increase drowsiness
    • be careful when driving a motor vehicle or operating machinery
  • STOP USE AND ASK A DOCTOR IF

    • you have trouble urinating or emptying your bladder
    • an allergic reaction to this product occurs. Seek medical help right away.


  • IF PREGNANT OR BREAST-FEEDING

    • if breast-feeding: not recommended 
    •  if pregnant: ask a health professional before use
  • KEEP OUT OF REACH OF CHILDREN


    In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

  • DIRECTIONS

                   

     adults 65 years of age and older
         		 
    • ask a doctor
     
     adults and children 12 to 64 years of age
         		 
    • take 1 tablet (5 mg) once daily in the evening  
    • do not take more than 1 tablet (5 mg) in 24 hours 
    • ½ tablet (2.5 mg) once daily in the evening may be appropriate for less severe symptoms
     
     children 6 to 11 years of age
         		 
    • take ½ tablet (2.5 mg) once daily in the evening 
    • do not take more than ½ tablet (2.5 mg) in 24 hours
     
     children under 6 years of age
         		 
    • do not use
     
     consumers with kidney disease
         		 
    • do not use
     

      


  • OTHER INFORMATION

    • store between 20° and 25°C (68° and 77°F)
    • safety sealed: do not use if carton was opened or if printed foil inner seal on bottle is torn or missing
    • safety sealed: do not use if carton was opened or if individual blister unit is open or torn



  • INACTIVE INGREDIENTS


    colloidal silicon dioxide, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, titanium dioxide.

  • QUESTIONS or COMMENTS?

    call 1-888-588-1418.

     


    Distributed by:
    Camber Consumer Care, Inc.

    Piscataway, NJ 08854, USA.


  • LEVOCETIRIZINE DIHYDROCHLORIDE TABLET, FILM COATED

    Label Image
  • INGREDIENTS AND APPEARANCE
    LEVOCETIRIZINE DIHYDROCHLORIDE 
    levocetirizine dihydrochloride tablet, film coated
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:50090-5341(NDC:69230-321)
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LEVOCETIRIZINE DIHYDROCHLORIDE (UNII: SOD6A38AGA) (LEVOCETIRIZINE - UNII:6U5EA9RT2O) LEVOCETIRIZINE DIHYDROCHLORIDE5 mg
    Inactive Ingredients
    Ingredient NameStrength
    LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    HYPROMELLOSE 2910 (3 MPA.S) (UNII: 0VUT3PMY82)  
    HYPROMELLOSE 2910 (6 MPA.S) (UNII: 0WZ8WG20P6)  
    POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)  
    POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
    Product Characteristics
    ColorWHITE (White to off white) Score2 pieces
    ShapeOVALSize8mm
    FlavorImprint Code H;LL
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:50090-5341-030 in 1 BOTTLE; Type 0: Not a Combination Product11/04/2020
    2NDC:50090-5341-190 in 1 BOTTLE; Type 0: Not a Combination Product11/04/2020
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA21351310/28/2020
    Labeler - A-S Medication Solutions (830016429)
    Establishment
    NameAddressID/FEIBusiness Operations
    A-S Medication Solutions830016429RELABEL(50090-5341) , REPACK(50090-5341)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!